- Home
- App-Analyse
- DoseEase for Users
- DoseEase for Users Vs. cubeTMFm
DoseEase for Users im Vergleich zu cubeTMFm Nutzung und Statistiken
DoseEase manages and monitors the drug administration data of clinical trials on blockchain in real-time. Blockchain securely protects vital data from corruption, tampering, and losses, thus guaranteeing the Integrity of Clinical Trial data
- Apple App Store
- Kostenlos
- Gesundheit und Fitness
Rang speichern
- -
cubeTMFm is a mobile app developed to provide smartphone access to cubeTMF® web services — CRScube’s trial master file (TMF) management solution for clinical trials.
App Features:
- Access and download TMF documents.
- eSign and QC documents per automated workflows.
- Upload document files using PDFs or images.
About the Web App:
cubeTMF® is CRScube’s web application for paperless trial master file (TMF) management. cubeTMF is fully scalable and exists securely on the cloud for global centralized access.
The system provides a simple, user-friendly interface and end-to-end features for constructing and managing a TMF repository as well as processing documents through automated eSign and QC workflows.
CRScube:
CRScube provides a comprehensive suite of eClinical solutions to CROs, Biotech, Pharmaceutical, Academic, and Non-Profit organizations globally. We are dedicated to providing the latest eClinical technology that is fast, flexible, and easy-to-use to streamline end-to-end operations for Phase I-IV, medical device, and Investigator-Initiated Trials.
- Apple App Store
- Kostenlos
- Medizin
Rang speichern
- -
DoseEase for Usersvs. cubeTMFm Ranking-Vergleich
Vergleichen Sie DoseEase for Users den Ranking-Trend der letzten 28 Tage mit cubeTMFm
Rang
Keine Daten verfügbar
DoseEase for Users im Vergleich zu cubeTMFm Ranking im Ländervergleich
Vergleichen Sie DoseEase for Users den Ranking-Trend der letzten 28 Tage mit cubeTMFm
Keine Daten zum Anzeigen
Stellen Sie mit unserer kostenlosen Testversion Vergleiche mit jeder Website an
DoseEase for Users VS.
cubeTMFm
Dezember 19, 2024